Ligand Pharmaceuticals, Inc. Balance Sheet
LGND / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Ligand Pharmaceuticals, Inc. had $1.6B in total assets and $1.0B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $174.9M | $72.3M | $23.0M | $45.0M | $19.5M | $47.6M | $71.5M | $117.2M | $20.6M | $18.8M | $97.4M | $160.2M | $11.6M | $12.4M | $7.0M |
| Accounts Receivable | $59.6M | $38.4M | $32.9M | $30.4M | $85.5M | $56.8M | $30.4M | $55.9M | - | - | - | - | - | - | - |
| Inventory | $9.1M | $14.1M | $24.0M | $13.3M | $27.3M | $26.5M | $7.3M | $7.1M | $4.4M | $1.9M | $1.6M | $269.0K | $1.4M | $1.7M | $1.3M |
| Current Assets | $832.3M | $331.6M | $237.4M | $263.6M | $464.8M | $500.6M | $1.1B | $870.5M | $237.0M | $163.1M | $214.7M | $185.2M | $24.9M | $23.8M | $32.2M |
| PP&E (Net) | $3.6M | $15.1M | $15.6M | $12.5M | $13.2M | $13.2M | $7.2M | $5.4M | $4.2M | $1.8M | $372.0K | $486.0K | $867.0K | $788.0K | $455.0K |
| Goodwill | $101.5M | $105.3M | $103.4M | $0 | $105.7M | $189.7M | $95.2M | $86.6M | $86.0M | $72.2M | $12.2M | $12.2M | $12.2M | $12.2M | $12.2M |
| Total Assets | $1.6B | $941.8M | $787.2M | $762.7M | $1.3B | $1.4B | $1.5B | $1.3B | $671.0M | $601.6M | $503.1M | $258.0M | $104.7M | $104.3M | $120.6M |
| Current Liabilities | $37.4M | $37.1M | $16.8M | $98.8M | $41.7M | $100.1M | $17.0M | $82.2M | $238.9M | $227.1M | $222.8M | $22.8M | $28.9M | $35.4M | $43.6M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | $27.5M | - |
| Shareholders' Equity | $1.0B | $830.4M | $700.9M | $597.5M | $821.2M | $709.5M | $767.2M | $560.9M | $399.8M | $341.3M | $237.3M | $26.3M | $49.6M | $26.5M | $8.2M |